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Abstract: Diabetes complication of kidney failure begins with poor control of High-
Density Lipoprotein (HDL) levels causing constriction of efferent arterioles 
affecting microalbuminuria, which triggers hypertension due to damage to blood 
vessels, with scarring in the filtration system of the central part of the kidneys. The 
Objective of the research was to analyze the influence of hypertension and HDL on 
the diabetic nephropathy patients. The study was an observational analytic study 
with a case-control design. The research sample consisted of 32 sample cases of 
patients with type II DM complications of kidney failure, and 32 control samples 
were DM type II patients without complications of kidney failure in dr. Pirngadi 
Hospital, Medan with accidental sampling technique. Data were generated by using 
questionnaires and medical records and analyzed by using the chi-square test, 
independent t-test, Mann-Whitney, and multivariate logistic regression to identify 
the effect of HDL and hypertension with DM type II complications of kidney 
failure. The Result of multivariate analysis showed hypertension OR; 17.845, and 
HDL OR; 7.049. The Conclusion showed that the most dominant factor that 
influenced the incidence of kidney failure complications in DM type II patients was 
hypertension at the Population Attributable Risk of 91%. 
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Abstrak: Diabetes komplikasi gagal ginjal diawali dengan kontrol kadar HDL yang buruk 
menyebabkan konstriksi arteriol eferen berpengaruh pada mikroalbuminuria yang memicu 
kejadian hipertensi merupakan akibat dari kerusakan pembuluh darah, dengan jaringan 
parut pada system filtrasi bagian utama dari ginjal. Tujuan penelitian adalah menganalisis 
pengaruh hipertensi dan HDL pada pasien nefropati diabetik. Metode penelitian adalah 
analitik observasional dengan desain kasus-kontrol, sampel penelitian terdiri dari 32 sampel 
kasus pasien DM Tipe II komplikasi gagal ginjal, dan 32 sampel kontrol pasien DM Tipe II 
tanpa komplikasi gagal ginjal di RSUD dr. Pirngadi, Medan dengan teknik accidental 
sampling. Data diperoleh dengan cara menggunakan kuisioner dan rekam medik serta 
dianalisis dengan menggunakan uji chi-square, independent t-test, mann-whitney, dan 
multivariat regresi logistik untuk melihat pengaruh HDL dan hipertensi dengan DM Tipe II 
komplikasi gagal ginjal. Hasil penelitian berdasarkan analisis multivariat diperoleh nilai 
risiko hipertensi OR: 17,845, HDL OR : 7,049. Kesimpulan penelitian ditemukan bahwa 
faktor yang paling dominan berpengaruh terhadap kasus DM Tipe II komplikasi gagagl 
ginjal adalah hipertensi dengan diperkuat nilai Population Attributable Risk 91%. 
 
Kata Kunci : DM tipe II; High-Density Lipoprotein; Hipertensi; Gagal ginjal  
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INTRODUCTION 
 
Diabetes mellitus (DM) is a collection of 
symptoms that arise in a person caused by an 
increase in blood glucose levels due to a decrease in 
progressive insulin secretion against the 
background of insulin resistance.1-5 In 2012, the 
World Health Organization (WHO) noted that in low 
and middle-income countries, more than 80% of 
deaths were caused by DM. By 2030, it is predicted 
that more than two-thirds (70%) of the global 
population will die from non-communicable 
diseases such as cancer, heart disease, stroke and 
DM.6,7 
DM is the most common cause of kidney 
failure that almost 44% of cases exist. Although DM 
can be controlled, this disease can still cause kidney 
failure. In a serious case, DM causes 28.5% 
retinopathy and a 60% reduction in lower 
limbs.8,9According to the 2014 International 
Diabetes Federation (IDF) data, in Indonesia, there 
was a 5.8% prevalence of DM. In 2013, Based on 
Basic Health Research or known as Riskesdas data, 
DM prevalence in Indonesia, based on interviews, 
diagnosed that it reached 1.5% and increased to 
2.1%.10,11 
The prevalence of DM in Indonesia based on 
interviews in 2013 was 2.1%. This figure is higher than 
in 2007, which was 1.1%. A total of 31 provinces 
(93.9%) showed a significant increase in DM 
prevalence.4 Riskesdas data in 2013 on the 
prevalence of DM in North Sumatra based on 
interviews diagnosed by doctors was 1.8%. A doctor 
diagnoses DM with 2.3%. The prevalence of DM 
patients in North Sumatra is almost close to the 
national average. North Sumatra has a prevalence 
of 5.3% or only 0.4% below the national average, 
which reached 5.7%. Patients who previously have 
known that they have DM are only 26%. Whereas 
most of those diagnosed with DM about 74% did not 
know and that they suffered from previous DM.12 
Based on the preliminary survey conducted 
at the dr. Pirngadi Hospital Medan, it was found the 
number of cases of DM with complications of 
kidney failure in 2012 as many as 20 cases, in 2013 as 
many as 6 cases, and in 2014 as many as 65 cases. 
Based on the description of the various literature 
above, it is necessary to research the cases of DM 
complications of kidney failure in dr. Pirngadi 
Hospital Medan. Based on the background, this 
study aims to identify the risk factors that affect DM 
cases of complications of kidney failure in particular 
to analyze the influence of hypertension and HDL in 
the incidence of kidney failure complications in DM 
type II patients at dr. Pirngadi Hospital, Medan. 
MATERIALS AND METHOD 
 
The study was an observational analytic 
study with a case-control design. This study was 
conducted in dr. Pirngadi Hospital, Medan, in 2015. 
The population of the case was all patients with 
type II DM who had complications of kidney failure 
and visited the dr. Pirngadi Hospital, Medan, in 2015. 
The control population was that all type II DM 
patients had no complications of kidney failure who 
visited the dr. Pirngadi Hospital, Medan, in 2015.  
The population in this study was all type II 
DM patients with complications of kidney failure 
who visited the dr. Pirngadi Hospital Medan with a 
total of 64 people. Case samples were obtained by 
calculating the sample size using the formula: 
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Information : 
n1 = n2 = Sample size 
α = Significance level of 5%, then the value of z=1.96 
zα = Normal deviation value α 5% = 1.96 
zβ = Normal deviation value β 20% = 0.842 
OR = Odds Ratio 
P = Proportion of risk factors 
Q = 1-p 
The sample size is based on several variables 
from previous studies, as shown in Table 1. Based 
on the results of the calculation, the maximum 
sample size of 29 after 10% of exposure is 32 people 
with DM type II complications of kidney failure. 
Therefore, the number of samples for the case 
group was 32 people with DM type II complications 
of kidney failure, and the control group was 32 
people with DM type II without complications of 
kidney failure. The comparison of cases with 
controls was 1:1 matched by age and gender. 
The analysis used in this study was bivariate 
analysis (Chi-square test, independent t-test, and 
Mann-Whitney test at a 95% degree of confidence) 
to identify influence variable (HDL and 
Hypertension) to DM type II complications of kidney 
failure, multivariate analysis (multiple logistic 
regression tests at a 95% degree of confidence) to 
identify higher influence variable (HDL and 
Hypertension) to DM type II complications of kidney 
failure, and Population Attributable Risk (PAR) to 
identify the percentage of prevention that can be 
carried out. 
 
Table 1. Sample Size based on Prior Research 
Variables OR P n1=n2 n+10% 
Family history 
Exercise Practice 
Blood Glucose Levels 
Systolic Blood Pressure  
6 
8 
3 
14 
0.001 
0.004 
0.0001 
0.0001 
13 
11 
29 
8 
14 
12 
32 
9 
 34 |  
 
Vol 20 No 1 
January 2020 
RESULT 
 
Table 2. The Frequency Distribution in dr. Pirngadi Hospital 
Medan based on The Risk Factors of Type II Diabetes Mellitus 
Patients 
Changeable Risk Factors 
DM Type II Complications of 
Kidney Failure 
Case Control 
N % n % 
Average HDL 
Not Good  
 
23 
 
71.9 
 
9 
 
28.1 
Good 9 28.1 23 71.9 
Total 32 100 32 100 
Hypertension 
Yes 
 
25 
 
78.1 
 
6 
 
18.8 
No 7 21.9 26 81.2 
Total 32 100 32 100 
 
In the univariate result in Table 2, the 
distribution of the average HDL in the highest HDL 
case group was not good (≤45mg / dl) with the 
proportion of 71.9%, while the highest HDL control 
group is good (>45mg/dl) with the proportion of 
71.9%. The highest distribution of hypertension in 
the case group in those with hypertension was 
78.1%, while the highest control group in those who 
did not have hypertension was 81.2%. 
In Table 3, it can be perceived that the Chi-
Square test results show that the variables that 
influence the incidence of Type II DM complications 
failure kidney were average HDL (p=<0.001), 
hypertension (p=<0.001).  
Table 4 show that the results of different 
means show that there are significant differences in 
mean HDL, systolic, and diastolic blood pressure 
between cases with controls (p<0.05). 
In Table 5, the results of multiple logistic 
regression tests show HDL averages (p = 0.022), 
and hypertension (p = 0.002 affect the incidence of 
Type II DM complications of kidney failure). The 
most dominant variable affecting the incidence of 
kidney failure in Type II DM patients in dr. Pirngadi 
Hospital, Medan, is hypertension with a regression 
coefficient value of 2.882 and Exp B (OR) 17.845.  
 
Table 3. The Effect of Risk Factors on Type II DM Complications 
of Kidney Failure  
Changeable 
Risk Factors 
 
DM Type II 
Complications of 
Kidney Failure P-Value 
OR 
(95% Cl) 
Case Control 
n % n % 
Average 
HDL Levels 
Not Good  
 
 
23 
 
 
71.9 
 
 
9 
 
 
28.1 <0.001 
2.55 
(1,53-4,24) 
Good  9 28.1 23 71.9 
Total 32 100 32 100 
Hipertensi 
Yes 
 
25 
 
78.1 
 
6 
 
18.8 
<0.001 
4.00 
(2,30-6,93) No 7 21.9 26 81.2 
Total 32 100 32 100 
 
 
Table 4. The Differences in Mean Risk Factors That Can Be 
Changed by Type II DM Complications of Kidney Failure 
Variables Mean P-Value 
HDL (mg/dl) 
Case 
Control 
Systolic (mmHg) 
Case 
Control 
Diastolic (mmHg) 
Case 
Control 
 
44.44 
70.19 
 
147.78 
129.25 
 
86.00 
71.97 
 
<0.001 
 
 
<0.001 
 
 
<0.001 
 
Table 5. The Final Results of Multiple Logistic Regression Tests 
Variables B Sig. 
Exp 
B(OR) 
95% CI 
Average HDL 1.953 0.022 7.049 1.327 - 37.433 
Hypertension 2.882 0.002 17.845 2.975 - 107.062 
Konstanta -4.325 0.000 0.013  
 
It indicates that if Type II DM sufferers experience 
kidney failure 18 times, they are more likely to have 
hypertension than Type II DM patients who do not 
experience kidney failure. 
The Percentage Correct value was 85.9%, 
indicating that the average variable HDL, 
hypertension, diet (diet), and duration of suffering 
from Type II DM explain the effect on the incidence 
of Type II DM complications of kidney failure in dr. 
Pirngadi Hospital, Medan is 85.9%, while the 
remaining 14.1% is influenced by other factors not 
included in this research variable. 
Calculating PAR value (Population 
Attributable Risk) on the most significantly 
influential variable with the highest OR (Odds 
Ratio). Hypertension, which is the most influential 
factor in the incidence of Type II DM complications 
of kidney failure, was obtained OR at 17.845 (95% 
CI=2.975-107.062) and p at 0.002 statistically 
significant.   
Therefore, PAR values were: 
 
 
 
91%
x100%
1117,8450,64
117,8450,64
PAR



  
 
It indicates that almost 91% of cases with the 
incidence of Type II DM complications of kidney 
failure can be prevented by correcting risk factors, 
namely hypertension, to normal blood pressure. 
 
DISCUSSION  
 
Based on the results of the bivariate analysis 
with independent t-test on systolic blood pressure 
and Mann-Whitney test on diastolic blood pressure, 
there were significant differences in mean systolic 
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and diastolic blood pressure between Type II DM 
patients complicating kidney failure (cases) with 
uncomplicated Type II DM patients kidney failure 
(control) (p <0.05). 
The result is in line with the result of the chi-
square test where there is a relationship between 
hypertension and the incidence of Type II DM 
complications of kidney failure obtained OR=4.00 
(95% CI=2.30-6.93). It means that Type II DM 
patients who experience failure kidney have a 
chance of 4.00 times hypertension compared to 
Type II DM patients who do not experience kidney 
failure. 
In line with the results of multivariate 
hypertension, the influence of the incidence of Type 
II DM complicating kidney failure was OR=17,845 
(95% CI=2,975-107,062), which indicates that Type II 
DM patients who had kidney failure had a chance of 
17,845 times hypertension compared to Type II DM 
patients who did not experience kidney failure. 
It is also in line with Arsono's research, 2015, 
in Prof. Dr. Margono Soekarjo Hospital Purwokerto 
which showed that the analysis of the influence of 
hypertension with the incidence of Type II DM 
complications of kidney failure obtained OR=14,15. 
The result indicates that Type II DM patients who 
experience kidney failure have a chance of 14.15 
times hypertension (systolic blood pressure 
≥140mmHg) compared to DM patients II who did 
not experience kidney failure. Furthermore, it 
statistically explained that there was a significant 
effect with a value of p <0.05.13 
Likewise, in the analysis of the influence of 
hypertension with the incidence of Type II DM 
complications of kidney failure which obtained 
OR=10.00, it means that Type II DM patients who 
have kidney failure have a chance of 10.00 times 
hypertension (diastolic blood pressure ≥90mmHg) 
compared to Type II DM patients who do not 
experience kidney failure and it statistically 
explained that there was a significant effect with a 
value of p <0.05.13 The results are in line with the 
research conducted by Dewi (2014) stating that the 
hypertension was influenced by diabetes.14 
According to another research by Wang 
(2017), diabetes mellitus and hypertension are 
major risk factors for chronic kidney injury, 
accounting with >70% of end-stage kidney disease.15 
In this study, we assessed interactions of 
hypertension and diabetes in causing kidney 
dysfunction, injury, and the role of endoplasmic 
reticulum (ER) stress. Hypertension was induced by 
aorta constriction (AC) between the renal arteries in 
6-month old male Goto-Kakizaki (GK) type 2 diabetic 
and control Wistar rats. Fasting plasma glucose 
averaged 162±11 and 87±2 mg/dL in GK and Wistar 
rats, respectively. AC produced hypertension in the 
right kidney (above AC) and near-normal blood 
pressure (BP) in the left kidney (below AC), with 
both kidneys exposed to the same levels of glucose, 
circulating hormones, and neural influences. After 8 
wks of AC, BP above the AC (and in the right kidney) 
increased from 109±1 to 152±5 mmHg in GK rats and 
from 106±4 to 141±5 mmHg in Wistar rats. The 
diabetic-hypertensive right kidneys in GK-AC rats 
had much more significant increases in albumin 
excretion and histological injury compared to left 
kidneys (diabetes only) of GK rats in the right 
kidneys (hypertension only) of Wistar-AC rats. The 
increase in ER stress and oxidative stress indicators 
was observed in diabetic-hypertensive kidneys of 
GK-AC rats. Inhibition of ER stress with 
tauroursodeoxycholic acid (TUDCA) for 6 wks 
reduced BP (135±4 vs. 151±4 mmHg), albumin 
excretion, ER and oxidative stress, and glomerular 
injury. Meanwhile,  it increases GFR in hypertensive-
diabetic kidneys. These results suggest that 
diabetes and hypertension interact synergistically 
to promote kidney dysfunction and injury via ER 
stress.15  
Having the highest PAR value of 91% indicates 
that almost 91% of cases with the incidence of Type 
II DM complications of kidney failure can be 
prevented by improving hypertension to have 
normal blood pressure. Furthermore, other 
research results show that hypertension was one of 
the many risk factors for diabetes.16 Other factors, 
such as HDL, LDL, triglycerides, can also contribute 
to the number of diabetes cases. Mengyang stated 
that, based on the results of his research, it could 
prevent diabetes by controlling these factors.16 
The multivariate results of average HDL 
influence the incidence of Type II DM complications 
of kidney failure, which obtained OR = 7.049 (95% 
CI=1.327-37,433). It indicates that Type II DM 
patients who experience kidney failure have a 
chance of 7.049 times, and the average HDL is not 
good (≤ 45mg/dl) compared to Type II DM patients 
who did not experience kidney failure. In line with 
Rodriguez-Poncelas’s research conducted in 2013 at 
the Spanish Hospital, it revealed the p-value=0.001 
(p <0.05), indicating that HDL influences the 
incidence of Type II DM complications of kidney 
failure.22 
On the other hand, it also showed a PAR value 
of 78% indicating that nearly 78% of cases with the 
incidence of Type II DM complications of kidney 
failure can be prevented by improving the poor 
quality of average HDL (≤45mg/dl) to have a good 
quality (>45mg / dl). 
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Moreover, High-density lipoprotein (HDL) has 
many antioxidant roles.17 The role of antioxidants in 
HDL is better with the support of the consumption 
of vegetables and fruit in patients with Type 2 
diabetes to prevent complications.17 Another 
research obtained results showing that the function 
of HDL as an anti-inflammatory can work effectively 
on patients with Type 2 DM before the patient has 
complications.23 However, its function will 
deteriorate if the condition of Type 2 DM patients is 
with complications.18 
The research by Nair (2016) in Pima Indian aims 
to look at protective factors for Type 2 DM in 
women.19 Based on the results of his research, it 
revealed that 12 of 21 women in Pima Indian showed 
a significant relationship between HDL and the 
incidence of Type 2 DM.19 In line with it, another 
research by Gourgari et al. (2019) stated that there 
are HDL influences on diabetes cases with a P-
value=0.0001.20 It is in line with another research 
stating that low HDL levels affect the incidence of 
diabetes with OR (6,818, P = 0.002).20,21,24 
 
CONCLUSION 
Based on the results of this study, it can be 
concluded that there was an influence of 
Hypertension on the incidence of Type II DM 
complications of kidney failure in dr. Pirngadi 
Hospital, Medan (OR = 17,845 (95% CI = 2,975-
107,062), and there was an influence of HDL on the 
incidence of Type II DM complications of kidney 
failure in dr. Pirngadi Hospital, Medan (OR = 7.049 
(95% CI = 1.327-37,433).  
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